Cartalax 20mg

Cartalax is a short tripeptide bioregulator associated with cartilage-focused and connective-tissue research. Published literature around AED and related ultrashort peptides discusses their investigation in gene-expression, stem-cell differentiation, and tissue-specific regulatory models, including chondrogenic pathways. The evidence base is niche and remains much more limited than the literature behind established orthopedic or rheumatologic therapies.

What Cartalax has been studied or discussed for

• cartilage-related research
• chondrogenic differentiation
• gene-expression regulation
• tissue-specific peptide bioregulation
• aging and connective-tissue signaling research

Relevant study
“Peptide Regulation of Chondrogenic Stem Cell Differentiation.” That paper specifically identifies the AED peptide as having chondroprotective / geroprotective relevance and discusses its effects on mesenchymal stem cells and chondrogenic differentiation.

Broader background source
“Peptide Regulation of Gene Expression: A Systematic Review,” which discusses AED among ultrashort peptides studied for gene-regulatory effects.